您的位置: 首页 > 农业专利 > 详情页

MESURE D'HÉMATOCRITE ET ESTIMATION DES VALEURS D'HÉMOGLOBINE AVEC UN SYSTÈME DE SURVEILLANCE DE SANG OPTIQUE NON INVASIF
专利权人:
FRESENIUS MEDICAL CARE HOLDINGS INC
发明人:
申请号:
EP09736721.3
公开号:
EP2355690B1
申请日:
2009.09.23
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
An optical blood monitoring system with a ratiometric model determines hematocrit values for a hemodialysis patient, from which hemoglobin values for the patient are estimated. The ratiometric model is calibrated, normally against a cell counter, using blood from a blood bank. The blood from a blood bank is preserved in a long term preservative which is typically different than that found in clinical settings. The hematocrit value determined by the ratiometric model is scaled by scaling factor so that the estimated hemoglobin level output from the monitor consistently matches that measured in a clinical setting. The hematocrit scaling factor is substantially about 1.033 when the patient's blood sample is stored in a short term preservative ethylene diamine tetra acetic, and is substantially about 1.06 when the hematocrit is measured in the blood sample without preservative being added to the blood sample. The hemoglobin value can also be adjusted for altitude.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充